Funding Opportunities

• Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed)
  (PAR-24-260)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
  (PAR-24-262)
  National Human Genome Research Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
  (PAR-24-263)
  National Human Genome Research Institute
  Application Receipt Date(s): December 2, 2024
• NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
  (PAR-24-269)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Investigating Mitochondrial-Nuclear Communication in AD/ADRD (R01 Clinical Trial Not Allowed)
  (RFA-AG-25-026)
  National Institute on Aging
  Application Receipt Date(s): November 07, 2024
• Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
  (RFA-CA-24-024)
  National Cancer Institute
  Application Receipt Date(s): October 31, 2024
• Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required)
  (RFA-CA-24-025)
  National Cancer Institute
  Application Receipt Date(s): October 31, 2024
• Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required)
  (RFA-CA-24-028)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
  (RFA-CA-25-011)
  National Cancer Institute
  Application Receipt Date(s): Not Applicable
• The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
  (RFA-CA-25-012)
  National Cancer Institute
  Application Receipt Date(s): Not Applicable
• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
  (RFA-DA-26-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)
  (RFA-DA-26-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R01 Clinical Trials Not Allowed)
  (RFA-DA-26-007)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed)
  (RFA-DA-26-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
  (RFA-DE-25-004)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
  (RFA-DK-25-015)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 14, 2024
• Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
  (RFA-DK-25-016)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 14, 2024
• Limited Competition for the Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional)
  (RFA-DK-25-017)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Single Source for the Continuation of the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
  (RFA-DK-25-018)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Not Applicable
• Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
  (RFA-FD-25-001)
  Food and Drug Administration
  Application Receipt Date(s): October 22, 2024, by 11:59 PM Eastern Time October 21, 2025, by 11:59 PM Eastern Time Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Late applications will not be accepted for this NOFO.
• Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
  (RFA-HD-25-003)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Application Receipt Date(s): Not Applicable
• Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
  (RFA-HG-24-021)
  National Human Genome Research Institute
  Application Receipt Date(s): December 02, 2024
• Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
  (RFA-HG-24-022)
  National Human Genome Research Institute
  Application Receipt Date(s): December 02, 2024
• Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
  (RFA-HG-24-023)
  National Human Genome Research Institute
  Application Receipt Date(s): December 02, 2024
• Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
  (RFA-NS-24-037)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.